Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/15/2014 07/16/2014 07/17/2014 07/18/2014 07/21/2014 Date
96.53(c) 96.83(c) 94.49(c) 97.2(c) 96.31(c) Last
1 558 375 1 618 852 1 634 985 1 964 400 1 152 827 Volume
-1.88% +0.31% -2.42% +2.87% -0.92% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
07/29Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 543 M
EBIT 2014 -637 M
Net income 2014 -682 M
Finance 2014 431 M
Yield 2014 -
Sales 2015 1 483 M
EBIT 2015 175 M
Net income 2015 83,9 M
Finance 2015 1 266 M
Yield 2015 -
PER 2014 -
PER 2015 282,93
EV / Sales 2014 41,1x
EV / Sales 2015 14,5x
Capitalization 22 748 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
4d ago VERTEX PHARMACEUTICALS : Assigned Patent
6d ago VERTEX PHARMACEUTICALS : Announces Retirement of Peter Mueller, Ph.D.
6d ago VERTEX PHARMACEUTICALS : Peter Mueller, Ph.D to Retire from Vertex Pharmaceutica..
7d ago VERTEX PHARMACEUTICALS : INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds In..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results on Ju..
07/14 NASDAQ 100 MOVERS : Vrtx, myl
07/14 VERTEX PHARMACEUTICALS : House Energy and Commerce Subcommittee on Health Hearin..
07/11 VERTEX PHARMACEUTICALS : MA : Change in Directors or Principal Officers (form 8-..
07/10 VERTEX PHARMACEUTICALS : Announces Retirement of Peter Mueller, Ph.D.
07/09 VERTEX PHARMACEUTICALS : Receives European CHMP Positive Opinion for KALYDECO&tr..
07/09 VERTEX PHARMACEUTICALS : Faruqi & Faruqi, LLP Encourages Investors Who Suffered ..
07/09 VERTEX PHARMACEUTICALS : Submits Supplemental New Drug Application sNDA to U.S. ..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Vertex Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF